Continuous peritoneal infusion of Shiga-like toxin II (SLT II) as a model for SLT II-induced diseases.
Barrett
T J
TJ
Division of Bacterial Diseases, Centers for Disease Control, Atlanta, Georgia.
Potter
M E
ME
Wachsmuth
I K
IK
D000818:Animals; D001427:Bacterial Toxins / Q000008:administration & dosage*; D003092:Colitis / Q000209:etiology* / Q000473:pathology; D003967:Diarrhea / Q000209:etiology; D004195:Disease Models, Animal; D004926:Escherichia coli; D004927:Escherichia coli Infections / Q000473:pathology; D006471:Gastrointestinal Hemorrhage / Q000209:etiology / Q000473:pathology; D006367:HeLa Cells; D006463:Hemolytic-Uremic Syndrome / Q000209:etiology* / Q000473:pathology; D006801:Humans; D007260:Infusion Pumps; D007263:Infusions, Parenteral; D007275:Injections, Intravenous; D011817:Rabbits; D022641:Shiga Toxin 2
D001427:Bacterial Toxins; D022641:Shiga Toxin 2